Workshop

WIN-CBB-Faculty of Health Mixer: Health Technologies

Camille Barre — Fri, 05 May 2023 17:27:33 +0000

WIN-CBB-Faculty of Health Mixer: Health Technologies Camille Barre Fri, 05/05/2023 - 13:27

The ��ݮ��Ƶ Institute for Nanotechnology (WIN), the Centre for Bioengineering and Biotechnology (CBB) and the Faculty of Health are pleased to present a joint workshop on the theme "Health Technologies." The event will be held on Friday May 5, 2023 from 9:00 a.m. to 1:30 p.m. EDT in QNC 1501. A networking lunch will be hosted after the presentations.

For more information, consult the link.

View Program

Failure Mode Effective Analysis

Aiju Chau — Mon, 19 Apr 2021 14:39:59 +0000

Failure Mode Effective Analysis Aiju Chau Mon, 04/19/2021 - 10:39

QMS Webinar Series: Failure Mode Effective Analysis

Speaker: Abdul Khalfan CQE, SSGB

Principal, Quality Assurance & Reliability Engineering Consulting Services

Failure Mode Effective Analysis

Failure Mode Effective Analysis better known as FMEA. It is an effective tool to provide decision making information to a Team of design, manufacturing, industrial, test, service, quality, and sustaining engineers, supply chain, maintenance personnel, program managers, management, and stakeholders at large to make value-added and pragmatic decisions to address chronic issues and ideas of improvements regarding their products/devices and services based upon objectiveness and not subjectiveness.

The concept of designing FMEA as a tool to address chronic and safety issues initiated in the 1960’s by the Aerospace industry during the Apollo missions, in the 1970’s by US Navy and Automotive industries.

There are four types of FMEA: i) System FMEA, ii) Design FMEA, iii) Process FMEA, and iv) Service FMEA.

The output of FMEA is based upon a ‘Risk Priority Number’ whose acronym is ‘RPN’. ‘RPN’ is calculated by taking into consideration the problem / issue at hand of its Severity multiplied by Occurrence multiplied by Detection or mathematically RPN = Severity X Occurrence X Detection. Typically, higher the ‘RPN’ number, higher the priority to address the issue at hand. However, this may or may not be applicable in each and every case as business decisions need to taken into account also.

The salient feature of FMEA is that it can be put into effect or practiced at any given point in time within the Product Life Cycle (PLC). It is or can be used to address problems/issues and improvement ideas for reliability, availability, serviceability, installability, and cost improvement.

About Abdul Khalfan:

Abdul Khalfan is a Quality Management Systems Professional (QMS) with extensive experience in the high-tech industry. His hands-on style and practical approach to business management makes him a natural catalyst for improvement initiatives. His unique career path and ground up experience has provided him with business and process insights leading to greater profitability, value-add, and efficacy for small, medium, and large companies and organizations such as NCR Corporation, Flextronics, Ingenico, Com Dev, Teledyne-Dalsa, ITT, Bell-Howell, KA Imaging, Curriato Inc., Schock Metal America Inc., Durose Steel, Honda Automotive, Kaparel, to name a few. Currently, he is providing Consulting Services for ISO 9001:2015 and ISO 13485:2016 Standards to Medical Device and non-medical companies in Kitchener-��ݮ��Ƶ area.
Abdul Khalfan consistently focused upon underperforming processes and products to higher levels of excellence and profitability. Using careful statistical analysis and a keen eye for value-add and process improvements he has been able to transform unproductive, wasteful practices into effective and value added process improvements.
Additionally, Abdul Khalfan, has established from ground zero the entire infra structure of QMS resulting in ISO 9001 Certification in the first audit; managed continuous improvement projects which in one case improved the ‘Early Life Performance’ of products by 47% resulting in savings of millions of dollars, significantly reduced the number of process steps and data consolidating North American data in one database saving 10 man days of work and savings of US$ 100,000 annually. Similarly, significantly streamlined and formalized haphazard and broken Engineering Change Request and Engineering Change Notice processes in a formal consolidated and automated process, thereby realizing its effectiveness, efficiency, reduced number of errors, timely execution, and cost savings.

Abdul Khalfan is an ASQ Certified Quality Engineer (CQE), SSGB, an Exemplar Global Certified Lead Auditor for ISO 9001:2015 and ISO 13485:2016 Standards, Certified Process Management and Improvement Trainer, holds Advanced Quality Assurance Diploma with an Electrical Engineering background.

He has been a frequent guest speaker at ASQ Meetings on Quality and Reliability subjects, part time instructor at Conestoga College on the subject of Total Quality Management (TQM), and is currently delivering Quality and Reliability workshops for UW CBB (Centre for Bio-Engineering and Biotechnology).

Abdul’s Consulting Services website address: www.qareconsulting.com.

Please contact cbb@uwaterloo.ca for the meeting link

CBB presents: System Level Test and Maturity Grid Risk Management with Abdul Khalfan

Carly Turnbull — Fri, 26 Mar 2021 17:30:01 +0000

CBB presents: System Level Test and Maturity Grid Risk Management with Abdul Khalfan Carly Turnbull Fri, 03/26/2021 - 13:30

QMS Webinar Series: System Level Test and Maturity Grid Risk Management

Speaker: Abdul Khalfan CQE, SSGB

Principal, Quality Assurance & Reliability Engineering Consulting Services

System Level Test – Product Qualification (also is categorized as Product Validation) Test Process

System Level Test is based upon ‘Process Management Methodology’ for establishing and maintaining Reliability and the integrity of a product from the Prototype phase to the end of its development cycle, i.e., ‘Product Qualification’.

System Level Test approach creates a focus on the relationships between internal and simulated external customer environment and suppliers and identifies the attributes of all required information, data, and data analysis for development and manufacture of reliable products.

The synopsis being, qualifying or validating a reliable new product to the market on time, meeting internal and external customers requirements as per the ‘Product Requirement Document (PRD)’ and Technical Specifications. Thereby, the company/organization benefits from its well-deserved reputation, customer satisfaction, and profitability!

Introduction to Product Quality Management Maturity Grid (PQMMG) – Risk Management Tool

PQMMG is a Risk Management Tool that realistically captures, records, and becomes a catalyst for mitigation of the actual Failures. Failures that occur throughout the Product Qualification process stages of Prototype, Design Verification, New Product Introduction (NPI), Manufacturing Process, Product Qualification (includes hardware, software, manufacturing, supply chain, service, packaging, and transportation).

PQMMG concept of ‘Risk Level’ is one of many tools that is available to assess the risk realistically that is involved during the Product Development transition stages. Experience has shown repeatedly that it keeps risk levels into perspective leaving no ambiguities during and after the Product Qualification process.

The salient feature of PQMMG is that the Risks which negatively impact the Reliability, Availability, Serviceability, Usability, and Install-ability (RASUI) are identified and agreed upon by the entire Development and Management Teams for their resolutions.

In conclusion, the ‘Product Quality Management Maturity Grid (PQMMG)’ is a conduit to minimize and mitigate the Product Risks at all levels depicted from the test results during its development stages to conform to the Product Requirements and Technical Specifications in a realistic manner. This will ultimately result in customer satisfaction!

About Abdul Khalfan:

Abdul’s Consulting Services website address: www.qareconsulting.com.

Please contact cbb@uwaterloo.ca for the meeting link

CBB presents: Quality Management Systems Webinar Series - Product Life Cycle with Abdul Khalfan

Charlotte Armstrong — Fri, 23 Oct 2020 14:52:26 +0000

CBB presents: Quality Management Systems Webinar Series - Product Life Cycle with Abdul Khalfan Charlotte Armstrong Fri, 10/23/2020 - 10:52

QMS Webinar Series: Product Life Cycle (PLC)

Speaker: Abdul Khalfan CQE, SSGB

Principal, Quality Assurance & Reliability Engineering Consulting Services

Product Life Cycle (PLC) refers to sequential phases from product planning to end of life. Generally, it comprises of six main stages, they are: i) Product Planning, ii) Design and Development, iii) Verification and Validation, iv) Production, v) Product Release/Field Follow/Sustaining Engineering and vi) End of Life of the Product.

i) Product Planning Phase – Product Planning is to identify customer needs, analyze business trends, and market competition, and develop product proposals. The document which describes and details this phase is known as Marketing Requirement Document (MRD).
ii) Design and Development Phase – This phase usually begins with preparation of detailed product requirements. These detailed requirements are documented and defined in a Product Requirement Document (PRD). Based upon the PRD, Technical Specifications are developed to conform to the Product Requirements as defined in the PRD and that truncates upwards to the MRD.
iii) Verification and Validation Phase – This phase consists of two major steps: Design Verification (DV) and Design Validation, also known as (DV). Once the design is completed, there is a design verification process which is paper based, i.e., Engineers and Technical Teams from cross-functional departments provide their input. If there is a consensus that the Design meets the Product Requirements as defined, a small no. of units are built for DV testing. These units are known as Prototypes.
Based upon the successful results of the Prototype units the Design Validation process commences. In this phase a statistical sample size of units are selected and extensively tested in accordance with the product requirements to ensure that the product will comply with the Reliability, Availability, Serviceability, Useability, and Installability better known as RASUI concepts. The intent is to provide a minimum of 80% statistical confidence level that the product is built right, i.e., as per its defined requirements.
iv) Production Phase – In this phase the Manufacturing process must be validated for Production readiness or Mass Production (MP).
v) Product Release Phase – Once the product has been validated for its design and manufacturing processes, and the product is officially released for the market place for sales and service sustaining Engineering or Current Engineering Team takes over from the parent Design Team and provides Technical and Maintenance support to the external customer installations. It is also known as Field Follow phase.
vi) End of Life (EOL) Phase – This is the terminal phase of a Product Life Cycle. The product is discarded, scrapped, or recycled when it is unable to continue or is not cost effective.

About Abdul Khalfan:

Abdul’s Consulting Services website address: www.qareconsulting.com.

Webinar viewing information will be sent with your registration confirmation email.

Ethics and Regulations, Conducting Research in Clinical Settings: A focus on Specific Cases with Carla Girolametto

Charlotte Armstrong — Fri, 23 Oct 2020 14:43:54 +0000

Ethics and Regulations, Conducting Research in Clinical Settings: A focus on Specific Cases with Carla Girolametto Charlotte Armstrong Fri, 10/23/2020 - 10:43

Speaker: Carla Girolametto, Director of Innovation, Research and Clinical Trials at Grand River Hospital.

This talk will focus on Ethics and Regulatory aspects of conducting research in a clinical setting with the involvement of Human Participants: An interactive case study.

Bio: Carla joined GRH in 2003 as a Clinical Research Coordinator with the opening of the Grand River Regional Cancer Centre. She took oversight of Clinical Trials in 2012, and became Director of the Innovation & Research program in 2018 . Carla holds a Master of Arts from the University of Venice in Italy, a Master of Science with a specialty in Clinical Research Administration from the George Washington University, U.S.A, and is currently working on her PhD at the University of ��ݮ��Ƶ.

Viewing information will be included in the registration confirmation email.

CBB presents: Quality Management Systems Webinar Series - Basic Concepts of Quality with Abdul Khalfan

Charlotte Armstrong — Tue, 20 Oct 2020 13:37:44 +0000

CBB presents: Quality Management Systems Webinar Series - Basic Concepts of Quality with Abdul Khalfan Charlotte Armstrong Tue, 10/20/2020 - 09:37

QMS Webinar Series: Basic Concepts of Quality

Speaker: Abdul Khalfan CQE, SSGB

Principal, Quality Assurance & Reliability Engineering Consulting Services

The central theme of ‘Basic Concepts of Quality’ is to imbed the fundamentals of ‘Quality’ concepts in everyday work life and in their interactions with the society at large.

The ‘Basic Concepts of Quality’ focuses on the thought process of Quality is everybody’s business! It is a never-ending journey of Continuous Improvement…… It defines and explains the following:

What is Quality?
What are the four absolutes of Quality?
What is Quality Based upon?
Definition of a Customer
Definition of a Supplier
What is a Process?
Process Management Model
System for Improving Quality
Performance Standard
Measurement of Quality
Price of Non-conformance (PONC)
Calculation of PONC
The Importance of Measurement
Individual’s Commitment
Typical Quality Systems
Closed Loop Corrective Action System ((CLCA)

About Abdul Khalfan:

Abdul Khalfan is a Quality Management Systems (QMS) seasoned professional with over 30 years of experience in Quality Assurance, Product Development and Validation, Reliability Engineering, and Continuous Improvement. He is detailed oriented in Process development, planning, designing, documenting, establishing, training, auditing, and successfully implementing QMS from ground zero that conform to ISO 9001 and ISO 13485 Standards. Abdul has deep Process Management and Improvement knowledge-know-how, and experience in Product Life Cycle, Product Validation, and Business Process Analysis. He has gained technical knowledge, experience, and management skills over the past 37 years through Fortune 500 companies, such as NCR, AT&T, Flextronics, Bell-Howell, ITT, First Data, Teledyne (Dalsa), as well as small, medium, and large high-tech corporations such as Ingenico, Com Dev, Ingenico, KA Imaging, Durose Steel Corporation, B.TE. Automotive, Curiato Inc., and the likes of it.

Abdul Khalfan has won several awards for product development, product validation, and product improvement and quality systems saving companies millions of dollars in cost improvements and minimizing waste!

Abdul’s work experience, knowledge, and know-how are in the high-tech, medical devices, space, automotive, steel, and packaging industries. His experience in Quality Assurance and Reliability Engineering spans from Canada, USA, Europe, China, Australia, New Zealand, Turkey, Middle East, and Pakistan.

Abdul is an American Society for Quality (ASQ) Certified Quality Engineer (CQE). Abdul has Quality Assurance and Advanced Quality Assurance Diplomas with an Electrical Engineering background. He is a Certified Process Management and Improvement (PM&I) Lead/ Facilitator from NCR Corporation and AT&T. He is KPMG and ASQ Certified Lead Auditor. Attained Project Management Certification from University of ��ݮ��Ƶ. Abdul is Certified in Six Sigma Green Belt (SSGB). He has achieved certification in ISO 9001 and ISO 13485 Standards.

Abdul was a part-time Instructor at Conestoga College Institute of Technology and Advanced Learning for teaching ‘Total Quality Management (TQM)’ Systems. Abdul has been a guest speaker at ASQ Kitchener Section, ASQ Quality Conferences, and Society of Manufacturing Engineers meetings on Quality related subjects.

Webinar viewing information will be sent with your registration confirmation email.

Save the date for the next QMS Webinar: Product Life Cycle on November 25!

U��ݮ��Ƶ Intellectual Property Workshop Series: TRADEMARKS

Charlotte Armstrong — Fri, 17 Jan 2020 14:56:57 +0000

U��ݮ��Ƶ Intellectual Property Workshop Series: TRADEMARKS Charlotte Armstrong Fri, 01/17/2020 - 09:56

IP Series events are open to all UW faculty, staff, students and post docs. Registration is required to ensure there is enough pizza and pop for all!

Download Poster

Workshop are presented by WatCo and supported by the Centre for Bioengineering and Biotechnology (CBB), the Games Institute, and Cryptoworks21 at the University of ��ݮ��Ƶ.

January 22

12:30-2:30 pm

QNC 1501

Trademarks *POSTPONED

Speakers: Eric Luvisotto, Michael Crinson (Aitken Klee LLP)

Did you know that the top five most valuable brands in the world in 2018 are all technology companies?

According to Forbes the most valuable brand in the world in 2018 was Apple (#1) with an estimated value of nearly $183 Billion dollars. By comparison, Coca-Cola's (#6) brand value in 2018 was over $57 Billion.

Come to the Trademark presentation and learn how to use this form of Intellectual Property (IP) protection to build the brand value of your technology or Start-Up.

About our speakers:

Eric Luvisotto (WatCo) is a registered Canadian Patent Agent (2003) and has earned his Master’s (1998) and Bachelor’s (1995) degrees in Engineering from the University of ��ݮ��Ƶ.

Eric has many years of experience in the field of Intellectual Property (IP), having dedicated his career to IP in 1999. His career spans a wide variety of experiences, including working for two Canadian IP law firms, founding and running his own Start-Up company, and working “in-house” for a large automotive parts manufacturer.

In 2008, Eric accepted the position of Technology Transfer Officer with the University of ��ݮ��Ƶ’s ��ݮ��Ƶ Commercialization Office (WatCo). In this role he analyzes new ideas for patentability and commercial potential; he also seeks out potential receptors of these new technologies and negotiates licensing agreements with them. He is also involved with the creation of Start-Up companies if the technology merits this pathway.

Eric has been a popular guest lecturer on Intellectual Property, having created several IP presentations for faculty and students at the University of ��ݮ��Ƶ including: “IP 101”, “IP Case Study”, “Copyright” and “Trademarks”. He also routinely gives talks to various UW groups (including New Faculty, Post Doc’s, Grad Students, Optometry, etc.) on WatCo’s services, UW’s IP policy and IP in general.

Eric is a member of the Intellectual Property Institute of Canada and is a member of their Bank of Speakers.

He is also a long standing member of the Licensing Executives Society, and past member of the Association of University Technology Managers.

Michael Crinson (Aitken Klee LLP) is one of Canada’s most experienced intellectual property law trial counsel and is recognized for his creative thinking to achieve optimal results and solutions to legal problems for his clients. Michael’s clients range from multinational corporations to start-ups, and from individuals to not-for-profit organizations. Prior to becoming a lawyer, Michael obtained a B.Sc. (Hons) in Biochemistry, and an M.Sc. in Biophysics.

Michael has been counsel on five separate trials in the past decade and has been counsel on numerous other contentious IP matters including patent, copyright, trademark, trade secret, and ownership and inventorship disputes. Michael has appeared as both trial and appellate counsel before the Federal, Ontario and Alberta courts in a variety of proceedings often in parallel with proceedings in jurisdictions including the United States, Europe, Australia and China.

In addition to being a lawyer, Michael is a qualified patent and trademark agent. He has been recognized for several years in Best Lawyers in Canada, the Legal 500 and the IAM Patent 1000. Most recently, Michael was named the IP Litigator of the Year (2017) in Ontario, and his Firm, Aitken Klee LLP was recognized as the Best IP Litigation Firm in Canada.

Health Canada Regulatory Insights Workshop

Charlotte Armstrong — Tue, 10 Sep 2019 15:48:46 +0000

Health Canada Regulatory Insights Workshop Charlotte Armstrong Tue, 09/10/2019 - 11:48

[Summary]

Gain insights into the Health Canada certification process for biomedical technologies and network with companies and ��ݮ��Ƶ researchers to support paths to certification.

Health Canada representatives will detail the process to obtain Health Canada approval for biomedical devices with:

Robotic humanoid and robotics applications
AI functionality and features
Wireless functionality from low Hz to sub-THz bands including mm-Wave

LOCATION: Engineering 7 second floor event space

Download Poster

AGENDA:

Talks by Health Canada representatives
- Colin Foster, Manager, Device Licensing Services Division
- Patrick Assouad, Senior Scientific Evaluator, Digital Health, Device Evaluation Division
Lunch
Open Q&A panel session: submit questions to cbb@uwaterloo.ca or use the hashtags #CBB #ASKHC anytime on social media.
Networking sessions, academic and industry posters
Tour select ��ݮ��Ƶ labs by appointment

Sponsors:

For more information, please email:

cbb@uwaterloo.ca

Biomedical Discussion Group: Dr. Diego L. Guarin, Postdoctoral Researcher Toronto Rehabilitation Institute and University of Toronto

Charlotte Armstrong — Thu, 11 Jul 2019 19:51:08 +0000

Biomedical Discussion Group: Dr. Diego L. Guarin, Postdoctoral Researcher Toronto Rehabilitation Institute and University of Toronto Charlotte Armstrong Thu, 07/11/2019 - 15:51

Dr. Diego L. Guarin

Postdoctoral Researcher Toronto Rehabilitation Institute and University of Toronto
Fellow of the Michael J. Fox Foundation for Parkinson's Research

Title: Deep Learning for Objective Assessment and Diagnosis of Neuromuscular Diseases

Download Poster

Abstract:

Many neuromuscular diseases, including stroke, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and Bell’s palsy, affect the orofacial musculature, inducing devastating functional, communication, and aesthetical impairments. Afflicted patients may have difficulty blinking, manipulating food and liquids in the mouth, and expressing themselves verbally and nonverbally. A timely and objective assessment of the orofacial impairment can contribute to the overall disease diagnosis, lead to early interventions, and provide objective means to quantify the effect of therapeutic, pharmaceutical, or surgical interventions. Currently, orofacial assessment relies on clinical evaluations performed by experts, or on the use of reflective markers and motion capture sensors. However, these approaches are expensive, time-consuming, and their reliability depends on the expertise of a trained practitioner. Computer vision and machine learning have the potential of transforming the assessment, diagnosis, and treatment of diseases affecting the orofacial musculature. These techniques have provided new approaches to evaluate orofacial function that are objective, automatic, easy to use, inexpensive, and mobile. In this talk, I will discuss how machine learning is disrupting the assessment and diagnosis of neuromuscular diseases, the challenges that must be overcome before successfully translating this research into clinical practice, and what are some interesting future directions.

Bio:

Diego L. Guarin completed his Ph.D. degree in Biomedical Engineering at McGill University, then moved to Harvard Medical School for a Postdoctoral Research Fellowship, and he is currently a fellow of the Michael J. Fox Foundation for Parkinson's Research working at the Toronto Rehabilitation Institute and Toronto University.

Dr. Guarin’s research focuses on the development and application of engineering, data science, and neuroscience approaches to improve our understanding of the human neuromuscular system, to improve the diagnosis of neuromuscular diseases, and to support the development of new rehabilitation options. During his graduate studies, Dr. Guarin developed new experimental and analytical techniques to quantify the neuromuscular properties of human joints. These techniques are used to quantify the joint rigidity of spastic patients and identify the mechanisms responsible for the abnormal joint stiffness, facilitating the diagnosis and treatment selection. Dr. Guarin’s postdoctoral research has focused on the fundamental problem of objectively measuring human movement, and on translating these measurements into objective and clinically useful metrics that can help in the diagnosis, assessment, and treatment of neuromuscular diseases. In particular, Dr. Guarin is working on novel non-contact technologies that utilize commercial grade cameras and machine learning algorithms to measure orofacial movements and improving the diagnosis of patients suffering from neuromuscular diseases such as stroke, ALS, Parkinson’s disease, and Bell’s palsy.

More information about publications and current projects can be found on GoogleScholar and ResearchGate websites.

Keywords: applied physiology, fatique, clinical depression, anxiety, gait, postural control, clinical mood presentations

Coffee and Timbits available - RSVP Required- Registration Link

Biomedical Discussion Group: Dr. Ali Boolani Clarkson University, New York, USA

Charlotte Armstrong — Tue, 25 Jun 2019 20:11:34 +0000

Biomedical Discussion Group: Dr. Ali Boolani Clarkson University, New York, USA Charlotte Armstrong Tue, 06/25/2019 - 16:11

Dr. Ali Boolani, Associate Professor, Clarkson University

Title: Feelings of energy and fatigue influence different aspects of gait and postural control

Download Poster

Abstract:

Until recently, energy and fatigue were viewed on a bipolar continuum, however, the work by Boolani and colleagues (2018, 2018, 2019) distinguishes the two moods as two distinct yet overlapping moods. Boolani and colleagues (2018) are further able to distinguish between stable persisting mood traits and transient feelings of mental and physical energy and fatigue as eight separate constructs. Studies with clinical depression and anxiety have noted that patients with these mood disorders have distinct gait patterns compared to those who do not qualify for a diagnosis. While the influences of clinical mood presentations on gait and posture have been extensively studied, sub-clinical/non-clinical mood states and their influences on gait and postural control are less well understood. Further, the studies that have focused on energy and fatigue and their role on gait and postural control have examined the two moods on a bipolar continuum rather than as two distinct unipolar moods. Additionally, the current work on energy and fatigue has primarily focused on fatiguing a certain muscle or muscle groups and then examining its influence on gait and postural control rather than examining the influence of subjective perceptions of energy and fatigue on gait and postural control. Our studies work on distinguishing the influence of perceptions of mental and physical energy and fatigue states and their influence on gait and postural control. Our research suggests that when examining the influences of these mood states on gait and postural control one must examine these moods separately.

Bio:

Dr. Ali Boolani is an associate professor at Clarkson University. He received his PhD in Applied Physiology at Oklahoma State University and completed a post-doctoral fellowship at the University of Georgia in Exercise Psychology. Ali’s work focuses on objective and subjective measurements of energy and fatigue, the influence of energy and fatigue on human movement, and interventions to improve feelings of energy and fatigue. His most recently published work showed that energy and fatigue are physiologically two distinct moods with current work displaying that energy and fatigue distinctly influence human movement.
His research interests include applied physiology of the human motor system, signal processing of intramuscular and surface electromyography and modeling of spinal neural networks.

Keywords: applied physiology, fatique, clinical depression, anxiety, gait, postural control, clinical mood presentations

Coffee and Timbits available - RSVP Required- Registration Link